Enhanced expression of VEGF following bFGF inhibition in non-small cell lung cancer cell lines

Hoang, 2002, Novel therapies for lung cancer, Surg Oncol, 11, 229, 10.1016/S0960-7404(02)00056-7 Ferreira, 2002, Novel approaches to the treatment of non-small cell lung cancer, Crit Rev Oncol Hematol, 41, 57, 10.1016/S1040-8428(01)00197-4 Takanami, 1996, The basic fibroblast growth factor and its receptor in pulmonary adenocarcinomas: an investigation of their expression as prognostic markers, Eur J Cancer, 32A, 1504, 10.1016/0959-8049(95)00620-6 Ueno, 2001, Increased serum levels of basic fibroblast growth factor in lung cancer patients: relevance to response of therapy and prognosis, Lung Cancer, 31, 213, 10.1016/S0169-5002(00)00187-2 Guddo, 1999, The expression of basic fibroblast growth factor (bFGF) in tumor-associated stromal cells and vessels is inversely correlated with non-small cell lung cancer progression, Hum Pathol, 30, 788, 10.1016/S0046-8177(99)90139-9 Kuhn, 2004, Influence of basic fibroblast growth factor in the proliferation of non-small cell lung cancer cell lines, Lung Cancer, 44, 174 Levin, 2004, Suppression of tumor growth and angiogenesis in vivo by a truncated form of 24-kd fibroblast growth factor (FGF)-2, Am J Pathol, 164, 1183, 10.1016/S0002-9440(10)63206-3 Ozen, 2004, Inhibition of proliferation and survival of melanoma cells by adenoviral-mediated expression of dominant negative fibroblast growth factor receptor, Melanoma Res, 14, 13, 10.1097/00008390-200402000-00003 Amoroso, 1997, Vascular endothelial growth factor: a key mediator of neoangiogenesis A review, Eur Rev Med Pharmacol Sci, 1, 17 Tsai, 1995, Vascular endothelial growth factor in human glioma cell lines: induced secretion by EGF, PDGF-BB, and bFGF, J Neurosurg, 82, 864, 10.3171/jns.1995.82.5.0864 Winer, 1999, Development and validation of real-time quantitative reverse transcriptase-polymerase chain reaction for monitoring gene expression in cardiac myocytes in vitro, Anal Biochem, 270, 41, 10.1006/abio.1999.4085 Pages, 2000, Signaling angiogenesis via p42/p44 MAP kinase cascade, Ann NY Acad Sci, 902, 187, 10.1111/j.1749-6632.2000.tb06313.x Iwasaki, 2004, Basic fibroblast growth factor (bFGF) and vascular endothelial growth factor (VEGF) levels, as prognostic indicators in NSCLC, Eur J Cardiothorac Surg, 25, 443, 10.1016/j.ejcts.2003.11.031 Rabie, 2004, Basic fibroblast growth factor up-regulates the expression of vascular endothelial growth factor during healing of allogeneic bone graft, Arch Oral Biol, 49, 1025, 10.1016/j.archoralbio.2004.05.012 Giavazzi, 2003, Distinct role of fibroblast growth factor-2 and vascular endothelial growth factor on tumor growth and angiogenesis, Am J Pathol, 162, 1913, 10.1016/S0002-9440(10)64325-8 Polytarchou, 2004, X-rays affect the expression of genes involved in angiogenesis, Anticancer Res, 24, 2941 Fersis, 2004, Changes in vascular endothelial growth factor (VEGF) after chemoendocrine therapy in breast cancer, Eur J Gynaecol Oncol, 25, 45 Kuhn, 2004, Candidate genes upregulated in density dependent growth inhibition of lung cancer cells, Int J Oncol, 25, 1481 Berra, 2000, Signaling angiogenesis via p42/p44 MAP kinase and hypoxia, Biochem Pharmacol, 60, 1171, 10.1016/S0006-2952(00)00423-8 Milanini, 1998, Pages G. p42/p44 MAP kinase module plays a key role in the transcriptional regulation of the vascular endothelial growth factor gene in fibroblasts, J Biol Chem, 273, 18165, 10.1074/jbc.273.29.18165 Mori, 2000, Mitogen-activated protein kinase, ERK1/2, is essential for the induction of vascular endothelial growth factor by ionizing radiation mediated by activator protein-1 in human glioblastoma cells, Free Radic Res, 33, 157, 10.1080/10715760000300711 Shi, 2005, In vitro study of HIF-1 activation and VEGF release by bFGF in the T47D breast cancer cell line under normoxic conditions: involvement of PI-3K/Akt and MEK1/ERK pathways, J Pathol, 205, 530, 10.1002/path.1734 Hortala, 2005, Identification of c-Jun as a critical mediator for the intracrine 24kDa FGF-2 isoform-induced cell proliferation, Int J Cancer, 114, 863, 10.1002/ijc.20744 Kohno, 2003, Pharmacological inhibitors of the ERK signaling pathway: application as anticancer drugs, Prog Cell Cycle Res, 5, 219 Solban, 2006, Mechanistic investigation and implications of photodynamic therapy induction of vascular endothelial growth factor in prostate cancer, Cancer Res, 66, 5633, 10.1158/0008-5472.CAN-06-0604